QQQ   420.51 (-0.68%)
AAPL   165.35 (-1.01%)
MSFT   400.89 (-0.84%)
META   490.29 (-2.29%)
GOOGL   154.81 (-0.77%)
AMZN   176.92 (-1.28%)
TSLA   149.38 (-0.37%)
NVDA   828.45 (-2.16%)
AMD   151.96 (-2.01%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   110.40 (-1.37%)
GE   152.07 (-0.57%)
CGC   8.07 (+3.07%)
DIS   112.17 (-0.23%)
AMC   3.06 (+4.79%)
PFE   25.47 (+0.32%)
PYPL   61.99 (-0.18%)
XOM   120.40 (+1.59%)
QQQ   420.51 (-0.68%)
AAPL   165.35 (-1.01%)
MSFT   400.89 (-0.84%)
META   490.29 (-2.29%)
GOOGL   154.81 (-0.77%)
AMZN   176.92 (-1.28%)
TSLA   149.38 (-0.37%)
NVDA   828.45 (-2.16%)
AMD   151.96 (-2.01%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   110.40 (-1.37%)
GE   152.07 (-0.57%)
CGC   8.07 (+3.07%)
DIS   112.17 (-0.23%)
AMC   3.06 (+4.79%)
PFE   25.47 (+0.32%)
PYPL   61.99 (-0.18%)
XOM   120.40 (+1.59%)
QQQ   420.51 (-0.68%)
AAPL   165.35 (-1.01%)
MSFT   400.89 (-0.84%)
META   490.29 (-2.29%)
GOOGL   154.81 (-0.77%)
AMZN   176.92 (-1.28%)
TSLA   149.38 (-0.37%)
NVDA   828.45 (-2.16%)
AMD   151.96 (-2.01%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   110.40 (-1.37%)
GE   152.07 (-0.57%)
CGC   8.07 (+3.07%)
DIS   112.17 (-0.23%)
AMC   3.06 (+4.79%)
PFE   25.47 (+0.32%)
PYPL   61.99 (-0.18%)
XOM   120.40 (+1.59%)
QQQ   420.51 (-0.68%)
AAPL   165.35 (-1.01%)
MSFT   400.89 (-0.84%)
META   490.29 (-2.29%)
GOOGL   154.81 (-0.77%)
AMZN   176.92 (-1.28%)
TSLA   149.38 (-0.37%)
NVDA   828.45 (-2.16%)
AMD   151.96 (-2.01%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   110.40 (-1.37%)
GE   152.07 (-0.57%)
CGC   8.07 (+3.07%)
DIS   112.17 (-0.23%)
AMC   3.06 (+4.79%)
PFE   25.47 (+0.32%)
PYPL   61.99 (-0.18%)
XOM   120.40 (+1.59%)

Abeona Therapeutics (ABEO) SEC Filings & 10K Form

$7.58
+0.05 (+0.66%)
(As of 10:11 AM ET)

Recent Abeona Therapeutics SEC Filings

DateFilerForm TypeView
03/19/2024
6:19 AM
Abeona Therapeutics (Filer)
Form DEF 14A
03/18/2024
7:36 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
6:35 AM
Abeona Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/15/2024
4:00 PM
Abeona Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
1:38 PM
Abeona Therapeutics (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SC 13G/A
02/12/2024
4:23 PM
Abeona Therapeutics (Subject)
Flynn James E (Filed by)
Form SC 13G/A
02/07/2024
7:30 AM
Abeona Therapeutics (Issuer)
Seshadri Vishwas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
3:30 PM
Abeona Therapeutics (Issuer)
Alvino Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:22 PM
Abeona Therapeutics (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G/A
01/08/2024
6:35 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2023
6:30 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
7:01 AM
Abeona Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2023
6:35 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2023
6:30 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2023
3:30 PM
Abeona Therapeutics (Issuer)
Seshadri Vishwas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
3:30 PM
Abeona Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/29/2023
4:16 PM
Abeona Therapeutics (Issuer)
O'Malley Brendan M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
4:17 PM
Abeona Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
4:25 PM
Abeona Therapeutics (Issuer)
Seshadri Vishwas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
6:30 AM
Abeona Therapeutics (Issuer)
Seshadri Vishwas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2023
8:00 AM
Abeona Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
8:00 AM
Abeona Therapeutics (Issuer)
O'Malley Brendan M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2023
7:30 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2023
6:30 AM
Abeona Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2023
7:10 PM
Abeona Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2023
9:41 AM
Abeona Therapeutics (Issuer)
Adage Capital Management, L.P. (Reporting)
ADAGE CAPITAL PARTNERS GP, L.L.C. (Reporting)
Adage Capital Partners, L.P. (Reporting)
Atchinson Robert (Reporting)
Gross Phillip (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/07/2023
7:41 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/06/2023
3:31 PM
Abeona Therapeutics (Subject)
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Form SC 13G/A
07/03/2023
7:54 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2023
7:34 AM
Abeona Therapeutics (Filer)
Form 424B5
06/21/2023
3:05 PM
Abeona Therapeutics (Issuer)
Amoroso Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2023
4:15 PM
Abeona Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/11/2023
6:30 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2023
6:30 AM
Abeona Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ABEO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners